{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:36:59Z","timestamp":1770334619243,"version":"3.49.0"},"reference-count":241,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.semnuclmed.2016.01.006","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T18:30:34Z","timestamp":1464287434000},"page":"340-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran"],"prefix":"10.1053","volume":"46","author":[{"given":"Amir Reza","family":"Jalilian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Beiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arman","family":"Hassanzadeh-Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parham","family":"Geramifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib1","first-page":"21","article-title":"Synthesis, formulation and quality control of Mebrofenin (BRIDA) as a 99mTc-KIT for cholescintigraphy","volume":"3","author":"Yaraghchi","year":"1995","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib2","first-page":"30","article-title":"Measurement of glomerular filtration rate with Tc-99m DTPA","volume":"1","author":"Eftekhari","year":"1993","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib3","first-page":"7","article-title":"Comparative assessment of renal Tc-99m DMSA scan and renal sonography findings in complication of urinary tract infections","volume":"10","author":"Alavi","year":"2002","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib4","first-page":"1","article-title":"Evaluation of ocular hydroxyapatite implant with Tc-99m MDP bone scan","volume":"6","author":"Eftekhari","year":"1998","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib5","first-page":"1","article-title":"Role of Tc-99m MIBI scintigraphy in diagnosis of malignant breast tumors","volume":"5","author":"Eftekhari","year":"1997","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib6","first-page":"25","article-title":"Sentinel node mapping for early breast cancer patients using 99mTc-phytate: Single center experience on 165 patients","volume":"20","author":"Dabbagh Kakhki","year":"2012","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib7","first-page":"4","article-title":"Imaging of medullary thyroid carcinoma with Tc-99m (V) DMSA","volume":"3","author":"Saghari","year":"1995","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib8","first-page":"6","article-title":"Comparison of Tc-99m Ethylenedicysteine (Tc-99m EC) with Tc-99m DPTA in evaluation of renal disease","volume":"4","author":"Eftekhari","year":"1996","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib9","first-page":"35","article-title":"Evaluation of role of brain SPECT in diagnosis of post stroke dementia","volume":"11","author":"Yousefipour","year":"2003","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib10","first-page":"50","article-title":"Tc-99m-RBC scan in diagnosis of hepatic hemangioma","volume":"2","author":"Eftekhari","year":"1994","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib11","first-page":"29","article-title":"Preparation of human serum albumin microspheres (MSA) kit for lung imaging in Iran","volume":"2","author":"Yaraghchi","year":"1994","journal-title":"Iran J NuclMed"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib12","unstructured":"www-pub.iaea.org\/mtcd\/publications\/pdf\/trs466_web.pdf"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib13","first-page":"27","article-title":"Preparation and labeling of HMPAO kit in Iran","volume":"8","author":"HadizadT","year":"2000","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib14","first-page":"57","article-title":"Production of 99mTc-antimony sulfide colloid for lymphoscintigraphy","volume":"11","author":"Shabani","year":"2003","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib15","first-page":"199","article-title":"Clinical evaluation of antimicrobial peptide [99mTc\/Tricine\/HYNIC0]ubiquicidin 29-41 as a human-specific infection imaging agent","volume":"36","author":"Gandomkar","year":"2009","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib16","first-page":"347","article-title":"99mTc-ubiquicidin [29-41]: A promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation","volume":"12","author":"Beiki","year":"2013","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib17","first-page":"20","article-title":"Clinical evaluation of 99mTc-MDP three phase bone scan and 99mTc-UBI [29-41] scintigraphy imaging in preferentially detection infection from sterile inflammation among diabetic patients with suspected foot infection","volume":"5","author":"Doroudi","year":"2015","journal-title":"IOSR J Pharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib18","first-page":"20","article-title":"Evaluation of 99mTc-Ubiquicidin 29-41 scintigraphy in differentiation of bacterial infection from sterile inflammation in diabetic foot","volume":"18","author":"Fard-Esfahani","year":"2010","journal-title":"Iran J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib19","first-page":"716","article-title":"Diagnostic value of 99mTc-ubiquicidin scintigraphy for osteomyelitis and comparisons with 99mTc-methylene diphosphonatescintigraphy and magnetic resonance imaging","volume":"32","author":"Assadi","year":"2011","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib20","first-page":"287","article-title":"Evaluation of a new radiolabeled bombesin derivative with 99mTc as potential targeted tumor imaging agent","volume":"298","author":"Sadeghzadeh","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib21","first-page":"103","article-title":"Evaluation of a new 99mTc-bombesin analog in differentiation of malignant from benign breast tumors","volume":"23","author":"Beiki","year":"2015","journal-title":"Iran J Nucl Med"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.01.006_bib22","first-page":"620","article-title":"Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions","volume":"35","author":"Shariati","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib23","first-page":"240","article-title":"Preparation and biological evaluation of [99mTc\/EDDA\/Tricine\/HYNIC0, BzThi3]-octreotide for somatostatin receptor-positive tumor imaging","volume":"28","author":"Erfani","year":"2013","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib24","first-page":"323","article-title":"Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: A case report","volume":"4","author":"FardEsfahani","year":"2010","journal-title":"J Med Case Rep"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib25","first-page":"77","article-title":"99mTc-Octreotide uptake in the uterus and a subserosalmyoma mimicking tumoral masses","volume":"42","author":"Pirayesh","year":"2014","journal-title":"J Nucl Med Technol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib26","first-page":"317","article-title":"Preparation of 99mTc-TRODAT-1 with high labeling yield in boiling water bath: A new formulation","volume":"41","author":"Erfani","year":"2014","journal-title":"Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib27","first-page":"15","article-title":"Development of a freeze-dried radiopharmaceutical kit for dopamine transporters imaging","volume":"23","author":"Erfani","year":"2015","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib28","first-page":"153","article-title":"Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson\u2019s disease versus other progressive movement disorders","volume":"30","author":"Fallahi","year":"2016","journal-title":"Ann Nucl Med"},{"issue":"13","key":"10.1053\/j.semnuclmed.2016.01.006_bib29","first-page":"686","article-title":"Establishment of a fast and high yield method for routine production of [131I]MIBG and investigation of its radiochemical stability for diagnosis and treatment uses","volume":"56","author":"Davarpanah","year":"2013","journal-title":"J Label Compound Radiopharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib30","first-page":"34","article-title":"Evaluation of [67Ga] citrate in the detection of various microorganism infections in animal models","volume":"17","author":"Jalilian","year":"2009","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib31","first-page":"41","article-title":"The radioisotope 67Ga (T1\/2 = 78h) in extensively used as single photon marker for detecting the presence","volume":"3","author":"Fateh","year":"1995","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib32","first-page":"45","article-title":"Sensitivity of gallium scintigraphy for evaluation of recurrent lymphoma: Comparison of planar and SPECT imaging","volume":"18","author":"Sadeghi","year":"2010","journal-title":"Iran J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib33","first-page":"479","article-title":"Determination of [201Tl]Tl(III) in [201Tl]TlCl solutions using HPLC","volume":"66","author":"Akhlaghi","year":"2008","journal-title":"Appl Radiat Isot"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib34","first-page":"109","article-title":"Preparation and evaluation of [201Tl](III)-DTPA complex for cell labeling","volume":"275","author":"Jalilian","year":"2008","journal-title":"J Radioanal Nucl Chem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib35","first-page":"8288","article-title":"Preoperative assessment of meningioma aggressiveness by Thallium-201 brain SPECT","volume":"23","author":"Mirfallah","year":"2015","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib36","first-page":"106","article-title":"Thallium-201 single photon emission tomography after injecting an antimuscarinic agent compared with computed tomography for the diagnosis of recurrent colorectal cancer: Report of three cases","volume":"9","author":"Fallahi","year":"2006","journal-title":"Hell J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib37","first-page":"34","article-title":"Radiolabelling of white blood cells with In-111 and Tc-99m","volume":"1","author":"Hadizad","year":"1993","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib38","first-page":"117","article-title":"Preparation and biodistribution of [111In]-rHuEpo for erythropoietin receptor imaging","volume":"278","author":"Sadeghpour","year":"2008","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib39","first-page":"210","article-title":"Cytotoxicity of 111In-oxine on mesenchymal stem cells: A time-dependent adverse effect","volume":"30","author":"Gholamrezanezhad","year":"2009","journal-title":"Nucl Med Commun."},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib40","first-page":"43","article-title":"Preparation of Indium Pentetate complex (111In-DTPA)","volume":"8","author":"Shahhosseini","year":"2000","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib41","first-page":"225","article-title":"Design and manufacture of krypton gas target for 81Rb production at a 30MeV cyclotron","volume":"55","author":"Aboudzadeh Rovais","year":"2010","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib43","first-page":"24","article-title":"Production and quality control of sodium fluoride (Na18F) and it\u2019s distribution in rat\u2019s lesions as PET radiopharmaceutical for bone scan","volume":"36","author":"Akhlaghi","year":"2006","journal-title":"Iran J Nucl Sci Technol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib44","first-page":"14","article-title":"Production and quality control of [18F]-FDG in Iran","volume":"7","author":"Jalilian","year":"1999","journal-title":"Iran J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib45","first-page":"39","article-title":"Determination of Kryptofix 2.2.2 concentration in [18F] FDG radiopharmaceutical","volume":"45","author":"Akhlaghi","year":"2008","journal-title":"J Nucl Sci Technol"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib46","first-page":"864","article-title":"Functional brain abnormalities localized in 55 chronic tinnitus patients: Fusion of SPECT coincidence imaging and MRI","volume":"30","author":"Farhadi","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib47","first-page":"275","article-title":"Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: A large randomized clinical trial","volume":"33","author":"Fallahi","year":"2012","journal-title":"Nucl Med Commun."},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib48","first-page":"1077","article-title":"Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer","volume":"33","author":"Fard-Esfahani","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib49","first-page":"777","article-title":"Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?","volume":"34","author":"Fallahi","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib50","first-page":"808","article-title":"Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma","volume":"35","author":"Fard-Esfahani","year":"2014","journal-title":"Nucl Med Commun."},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib51","first-page":"169","article-title":"Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule","volume":"30","author":"Zakavi","year":"2009","journal-title":"Nucl Med Commun."},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib52","first-page":"52","article-title":"Gonadal function in patients with differentiated thyroid cancer treated with (131)I","volume":"7","author":"Esfahani","year":"2004","journal-title":"Hell J Nucl Med."},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib53","first-page":"277","article-title":"Incidence of second primary malignancies during a long-term surveillance of patients with differentiated thyroid carcinoma in relation to radioiodine treatment","volume":"36","author":"Fallahi","year":"2011","journal-title":"ClinNucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib54","first-page":"206","article-title":"Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment","volume":"7","author":"Esfahani","year":"2004","journal-title":"Hell J Nucl Med."},{"issue":"9","key":"10.1053\/j.semnuclmed.2016.01.006_bib55","first-page":"696","article-title":"The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma","volume":"32","author":"Fard-Esfahani","year":"2007","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib56","first-page":"37","article-title":"Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma","volume":"12","author":"Fard-Esfahani","year":"2009","journal-title":"Hell J Nucl Med."},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.01.006_bib57","first-page":"510","article-title":"The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131 I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: A pilot study","volume":"18","author":"Hamidieh","year":"2014","journal-title":"Pediatr Transplant"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib58","first-page":"12","article-title":"Production, quality control and biological evaluation of 153Sm-EDTMP in wild-type rodents","volume":"17","author":"Bahrami-Samani","year":"2009","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib59","first-page":"28","article-title":"Treatment efficacy of 153Sm-EDTMP for painful bone metastasis","volume":"1","author":"Ayati","year":"2013","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib60","first-page":"26","article-title":"Effectiveness and complications of 153Sm-EDTMP in palliative treatment of diffuse skeletal metastases","volume":"21","author":"Beiki","year":"2013","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib61","first-page":"137","article-title":"Production, quality control and pharmacokinetic studies of177Lu-EDTMP for human bone pain palliation therapy trialsservices","volume":"11","author":"Bahrami-Samania","year":"2012","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib62","first-page":"109","article-title":"Metastatic bone pain palliation using 177Lu\u2011Ethylenediaminetetramethylene Phosphonic Acid","volume":"14","author":"Alavi","year":"2015","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib63","first-page":"47","article-title":"Development of 90Y-chitosan as a new agent for radiosynovectomy","volume":"306","author":"Zolghadri","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib64","first-page":"59","article-title":"Efficacy of radiosynovectomy in the treatment of chronic knee synovitis: Systematic review and meta-analysis","volume":"23","author":"Norouzbeigi","year":"2015","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib65","first-page":"182","article-title":"(32)P colloid radiosynovectomy in treatment of chronic haemophilicsynovitis: Iran experience","volume":"13","author":"Mortazavi","year":"2007","journal-title":"Haemophilia"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib66","first-page":"30","article-title":"Management of cystic craniopharyngiomas with intracavitary irradiation with 32P","volume":"11","author":"Shahzadi","year":"2008","journal-title":"Arch Iran Med."},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib67","first-page":"9","article-title":"production of 188-re sulphide colloid for knee joints arthritis treatment and acidity, molar ratio and ultrasonic time optimization","volume":"62","author":"Davarpanah","year":"2013","journal-title":"J Nucl Sci Technol"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib68","first-page":"192","article-title":"Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal metastases","volume":"41","author":"Pirayesh","year":"2013","journal-title":"J Nucl Med Technol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib69","first-page":"44","article-title":"Effectiveness and complications of 188Re-HEDP in palliative treatment of diffuse skeletal metastases","volume":"23","author":"Beiki","year":"2015","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib70","first-page":"113","article-title":"Cyclotron production of technetium radionuclides using natural metallic molybdenum target and consequent preparation of 99mTc-BRIDA as a sample radiopharmaceutical","volume":"55","author":"Targholizadeh","year":"2010","journal-title":"Nukleonika"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib71","first-page":"187","article-title":"Direct technetium radiopharmaceuticals production using a 30MeV Cyclotron","volume":"19","author":"Jalilian","year":"2011","journal-title":"DARU"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib72","first-page":"279","article-title":"Preparation and biodistribution of 99mTc-IgG-HYNIC in normal rats","volume":"54","author":"Rajabifar","year":"2009","journal-title":"Nukleonika"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.01.006_bib73","first-page":"709","article-title":"Development of a 99mTc-labeled lactam bridge-cyclized alpha-MSH derivative peptide as a possible single photon imaging agent for melanoma tumors","volume":"29","author":"Shamshirian","year":"2015","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib74","first-page":"169","article-title":"Synthesis, radiolabeling and stability of new nitophenol complexes of technetium-99m, as possible hypoxia imaging radiopharmaceuticals","volume":"267","author":"Jalilian","year":"2006","journal-title":"J Radioanal Nucl Chem"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.01.006_bib75","first-page":"419","article-title":"Synthesis and evaluation of a 99mTc-labeled tubulin-binding agent for tumor imaging","volume":"57","author":"Erfani","year":"2014","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib76","first-page":"125","article-title":"A 99m Tc-tricine-HYNIC-labeled peptide targeting the neurotensin receptor for single-photon imaging in malignant tumors","volume":"57","author":"Erfani","year":"2014","journal-title":"J Label Compd Radiopharm"},{"issue":"12","key":"10.1053\/j.semnuclmed.2016.01.006_bib77","first-page":"627","article-title":"99mTc-tricabonyl labeling of ofloxacin and its biological evaluation in Staphylococcus aureus as an infection imaging agent","volume":"56","author":"Erfani","year":"2013","journal-title":"J Label Compd Radiopharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib78","first-page":"227","article-title":"Synthesis, radiolabeling and bioevaluation of a novel arylpiperazine derivative containing triazole as a 5-HT1A receptor imaging agents","volume":"40","author":"Hassanzadeh","year":"2013","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib79","first-page":"87","article-title":"Comparison of 99mTc-labeled PR81 and its F(ab\u2019)2 fragments as radioimmunoscintigraphy agents for breast cancer imaging","volume":"25","author":"Salouti","year":"2011","journal-title":"AnnNucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib80","first-page":"97","article-title":"Synthesis and preliminary evaluation of a new 99mTc labeled substance P analogue as a potential tumor imaging agent","volume":"14","author":"Mozaffari","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib81","first-page":"709","article-title":"A 99mTc-tricine-HYNIC-labeled peptide targeting the melanocortin-1 receptor for melanoma imaging","volume":"29","author":"Shamshirian","year":"2015","journal-title":"Ann Nucl Med"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib82","first-page":"91","article-title":"Development of 111In-DTPA-human polyclonal antibody complex for long-term inflammation\/infection detection","volume":"50","author":"Jalilian","year":"2005","journal-title":"Nukleonika"},{"issue":"9","key":"10.1053\/j.semnuclmed.2016.01.006_bib83","first-page":"653","article-title":"Preparation and biodistribuion assessment of 111In-BPAMD as a novel agent for bone SPECT imaging","volume":"103","author":"Yousefnia","year":"2015","journal-title":"Radiochim Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib84","first-page":"911","article-title":"Development of 111In DOTMP for dosimetry of bone pain palliation agents","volume":"304","author":"Yousefnia","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib85","first-page":"26","article-title":"Preparation and quality control of 111In-Plerixafor for chemokine receptor type4 imaging","volume":"5","author":"Aghanejad","year":"2015","journal-title":"Recent Pat Top Imaging"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib86","first-page":"163","article-title":"Development of In-111-DTPA-bis-alendronate complexes for bone pain palliation therapy","volume":"2","author":"Fakhari","year":"2016","journal-title":"Front Biomed Technol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib87","first-page":"2361","article-title":"Development of an 111In-labeled dihydropyridine complex for L-type calcium channel imaging","volume":"303","author":"Firouzyar","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib88","first-page":"112","article-title":"Preclinical evaluation of [111In]-DOTA-trastuzumab for clinical trials","volume":"10","author":"Alirezapour","year":"2014","journal-title":"J Cancer Res Ther"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib89","first-page":"95","article-title":"Development of 111In-labeled porphyrins for SPECT imaging","volume":"2","author":"Sadeghi","year":"2014","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib90","first-page":"28","article-title":"Radiosynthesis and biological evaluation of [111In]-5, 10, 15, 20-tetrakis (pentafluorophenyl) porphyrin complex as a possible imaging agent","volume":"2","author":"Fazaeli","year":"2012","journal-title":"Int J Nucl Energy Sci Eng"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib91","first-page":"577","article-title":"Synthesis, radiolabeling and quality control of 111In-DOTA-bevacizumab for radioimmunoscintigraphy of VEGF receptors","volume":"101","author":"Khorami-Moghadam","year":"2013","journal-title":"Radiochim Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib92","first-page":"58","article-title":"Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with 90Y and 111In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin\u2019s Lymphoma","volume":"22","author":"Gholipour","year":"2014","journal-title":"DARU"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib93","first-page":"791","article-title":"Development of In-111 labeled insulin for receptor imaging\/therapy","volume":"279","author":"Jalilian","year":"2009","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib94","first-page":"113","article-title":"Development of [111In]-DTPA-Buserelin for GnRH receptor studies","volume":"98","author":"Jalilian","year":"2010","journal-title":"Radiochim Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib95","first-page":"151","article-title":"Preparation, Quality control and biodistribution studies of two [111In]-Rituximab immunoconjugates","volume":"76","author":"Jalilain","year":"2008","journal-title":"Sci Pharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib96","first-page":"8","article-title":"Indium-111 maltolate complex as a cell labeling agent for SPECT imaging","volume":"20","author":"Jalilian","year":"2012","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib97","first-page":"20","article-title":"Radiosynthesis and biological evaluation of [111In]-tris [8-Hydroxy-2-methylquinoline] complex as a possible imaging agent","volume":"19","author":"Fazaeli","year":"2011","journal-title":"Iran J Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib98","first-page":"19","article-title":"Preparation of [111In]Bleomycin","volume":"23","author":"Jalilian","year":"2005","journal-title":"Iran J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib99","first-page":"731","article-title":"HPLC analysis of radiogallium labeled proteins using a two solvent system","volume":"36","author":"Jalilian","year":"2013","journal-title":"J Liq Chromatogr Relat Technol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib100","first-page":"555","article-title":"Biological evaluation of [67Ga]-DTPA-glucagon for SPECT imaging","volume":"285","author":"Jalilian","year":"2010","journal-title":"J Radioanal NuclChem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib101","first-page":"115","article-title":"Preparation and biodistribution studies of [67Ga]2-acetylpyridine 4,4-dimethyl thiosemicarbazone complex as a possible SPECT tracer for detection of malignancies","volume":"272","author":"Haghighi Moghadam","year":"2007","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib102","first-page":"343","article-title":"Evaluation of a [67Ga]-Thiosemicarbazone complex as tumor imaging agent","volume":"77","author":"Jalilian","year":"2009","journal-title":"Sci Pharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib103","first-page":"523","article-title":"Preparation and biodistribution studies of a radiogallium-acetylacetonate bis (thiosemicarbazone) complex in tumor-bearing rodents","volume":"11","author":"Jalilian","year":"2012","journal-title":"Iran J Pharm Res"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib104","first-page":"29","article-title":"Synthesis and Evaluation of [67Ga]-AMD3100; a novel imaging agent for targeting chemokine receptor CXCR4","volume":"82","author":"Aghanejad","year":"2014","journal-title":"Sci Pharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib105","first-page":"355","article-title":"Production and quality control of 67Ga-DOTA-trastuzumab for radioimmunoscintigraphy","volume":"12","author":"Alirezapour","year":"2013","journal-title":"Iran J Pharm Res"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib106","first-page":"735","article-title":"Radiosynthesis and quality control of [67Ga]-3,4-dimethoxylated porphyrin complex as a possible imaging agent","volume":"12","author":"Paknafas","year":"2013","journal-title":"Iran J Pharm Res"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib107","first-page":"17","article-title":"Preparation and Evaluation of [67Ga]-Tetra phenyl porphyrin complexes as imaging agents","volume":"288","author":"Fazaeli","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib108","first-page":"1695","article-title":"Development of radiolabeled radachlorin complex as a possible tumor targeting agent","volume":"303","author":"Fazaeli","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib109","first-page":"755","article-title":"Development of Ga-67 maltolate complex as a tumor imaging agent","volume":"11","author":"Fazaeli","year":"2012","journal-title":"Iran J Pharm Res"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib110","first-page":"37","article-title":"Estimation of human effective absorbed dose of 67Ga-DTPA-gonadorelin based on biodistribution rat data","volume":"32","author":"Shanehsazzadeh","year":"2011","journal-title":"Nucl Med Commun"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.01.006_bib111","first-page":"287","article-title":"Development of 67Ga-DTPA-Streptokinase for DVT Imaging","volume":"43","author":"Jalilian","year":"2009","journal-title":"Pharm Chem J"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib112","first-page":"105","article-title":"Preparation and biodistribution of [67Ga]-labeled-oxytocin for SPECT purposes","volume":"7","author":"Jalilian","year":"2009","journal-title":"Iran J Radiat Res"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib113","first-page":"51","article-title":"Preparation and biological evaluation of [67Ga]-labeled-superparamagnetic nanoparticles in normal rats","volume":"97","author":"Jalilian","year":"2009","journal-title":"Radiochim Acta"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib114","first-page":"123","article-title":"Preparation and Evaluation of [67Ga]-DTPA-gonadorelin in normal rats","volume":"278","author":"Jalilian","year":"2008","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib115","first-page":"435","article-title":"Preparation and Evaluation of [67Ga]-DTPA-b1-24-corticotrophin in normal rats","volume":"96","author":"Jalilian","year":"2008","journal-title":"Radiochim Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib116","first-page":"71","article-title":"Evaluation of [67Ga]-Insulin for insulin receptor imaging","volume":"10","author":"Jalilian","year":"2007","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib117","first-page":"167","article-title":"Preparation, Quality control and Biodistribution studies of [67Ga]-DOTA-anti-CD20","volume":"96","author":"Jalilian","year":"2008","journal-title":"Radiochim Acta"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib118","first-page":"175","article-title":"Preparation and Biodistribution of [67Ga]-DTPA-Rituximab in normal rats","volume":"274","author":"Jalilian","year":"2007","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib119","first-page":"24","article-title":"Dynamic distribution of 67Ga-Bleomycin complex in normal mice","volume":"1","author":"Tabeie","year":"2003","journal-title":"Iran J Pharmacol Ther"},{"issue":"12","key":"10.1053\/j.semnuclmed.2016.01.006_bib120","first-page":"1127","article-title":"Preparation and preliminary biological evaluation of radiogallium-labeled DTPA-amlodipine complex for possible L-type calcium channel imaging","volume":"102","author":"Firouzyar","year":"2014","journal-title":"Radiochim Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib121","first-page":"204","article-title":"Evaluation of radiogallium-labeled, folate embedded superparamagnetic nanoparticles in fibrosarcoma-bearing mice","volume":"8","author":"Hosseini-Salekdeh","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib122","first-page":"49","article-title":"Development of radiogallium-ethylenecysteamine cysteine complex as a possible renal imaging agent","volume":"284","author":"Jalilian","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib123","first-page":"309","article-title":"Preclinical evaluation of a new bombesin analog for imaging of gastrin-releasing peptide receptors","volume":"26","author":"Shirmardi","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib124","unstructured":"www-pub.iaea.org\/MTCD\/publications\/PDF\/trs468_web.pdf"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib125","first-page":"4","article-title":"Preparation and quality Control of [57Co]Bleomycins","volume":"38","author":"Jalilian","year":"2006","journal-title":"Iran J Nucl Sci Technol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib126","first-page":"194","article-title":"Feasibility and improvement in production of 191Os\/191mIr generator by Tehran Research Reactor (TRR)","volume":"40","author":"Salek","year":"2012","journal-title":"Ann Nucl Energy"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib127","first-page":"53","article-title":"Radiosynthesis of 191Os-2-acetylpyridine thiosemicarbazone complex, as an in vivo therapeutic radionuclide generator","volume":"21","author":"Moghaddam-Banaem","year":"2013","journal-title":"Iran J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib128","first-page":"543","article-title":"Development of an in vivo radionuclide generator by labeling bleomycin with 191Os","volume":"290","author":"Jamre","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib129","first-page":"659","article-title":"Synthesis of [75Se]5-ethoxycarbonyl-4-methyl-1,2,3-selenadiazole","volume":"60","author":"Jalilian","year":"2004","journal-title":"Int J Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib130","first-page":"208","article-title":"Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent","volume":"49","author":"Mirzaei","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib131","first-page":"19","article-title":"Preclinical study of 68Ga-DOTATOC: Biodistribution assessment in syrian rats and evaluation of absorbed dose in human organs","volume":"4","author":"Naderi","year":"2016","journal-title":"Asia Ocean J Nucl Med Biol"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib132","first-page":"29","article-title":"Optimized production and quality control of 68Ga-DOTATATE","volume":"24","author":"Aghanejad","year":"2016","journal-title":"Iran J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib133","first-page":"506","article-title":"Optimized production and quality control of 68Ga-EDTMP for small clinical trials","volume":"29","author":"Mirzaie","year":"2015","journal-title":"Ann Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib134","first-page":"725","article-title":"Development of 68Ga ethyl cysteinate dimer for PET studies","volume":"307","author":"Mirzaei","year":"2016","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib135","article-title":"Preclinical evaluation of 68Ga-MAA from commercial available 99mTc-MAA kit","author":"Shanehsazzadeh","year":"2016","journal-title":"Iran J Pharm Res"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib136","first-page":"99","article-title":"Production and quality control of [68Ga]Citrate for PET applications","volume":"3","author":"Aghanejad","year":"2015","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib137","first-page":"20","article-title":"Development of a 68Ga-fluorinated porphyrin complex as a possible PET imaging agent","volume":"46","author":"Fazaeli","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib138","first-page":"247","article-title":"Development of a Ga-68 labeled triptorelin analog for GnRH receptor imaging","volume":"104","author":"Zoghi","year":"2016","journal-title":"Radiochimica Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib139","first-page":"92","article-title":"Production and application of copper radiopharmaceuticals","volume":"2","author":"Jalilian","year":"2009","journal-title":"Curr Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib140","first-page":"166","article-title":"Production of Copper-64 diacetyl-bis (n4-methylthiosemi-carbazone) for therapeutic purposes","volume":"7","author":"Jalilian","year":"2008","journal-title":"World J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib141","first-page":"14","article-title":"Production, quality control and imaging of 64Cu-ATSM in healthy rabbits for PET applications","volume":"18","author":"Fazaeli","year":"2010","journal-title":"Iran J Nucl Med"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib142","first-page":"6","article-title":"Production and tumour uptake of [64Cu]pyruvaldehyde-bis (N4-methylthiosemicarbazone)for PET and\/or therapeutic purposes","volume":"10","author":"Jalilian","year":"2007","journal-title":"Nucl Med Rev Cent East Eur"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib143","first-page":"73","article-title":"Development of [64Cu]-DOTA-PR81 radioimmunoconjugate for MUC-1 positive PET imaging","volume":"43","author":"Alirezapour","year":"2016","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib144","first-page":"1261","article-title":"Optimized preparation and preliminary evaluation of [64Cu]\u2013DOTA\u2013trastuzumab for targeting ErbB2\/Neu expression","volume":"295","author":"Alirezapour","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib145","first-page":"563","article-title":"Development of [64Cu]-DOTA-anti-CD20 for targeted therapy","volume":"274","author":"Jalilian","year":"2007","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib146","first-page":"255","article-title":"Preparation, nano purification, quality control and labeling optimization of [64Cu]-5,10,15,20-tetrakis (pentafluoro phenyl) porphyrin complex as a possible imaging agent","volume":"295","author":"Fazaeli","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib147","first-page":"1563","article-title":"An overview of copper radionuclides and production of 61Cu by proton irradiation of natZn at a medical cyclotron","volume":"64","author":"Rowshanfarzad","year":"2006","journal-title":"Appl Radiat Isotopes"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib148","first-page":"147","article-title":"Production and quality control of 66Ga radionuclide","volume":"51","author":"Sabet","year":"2006","journal-title":"Nukleonika"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib149","first-page":"38","article-title":"Production, formulation and quality control of [13N]NH3 compound for PET imaging of regional blood flow","volume":"13","author":"Jalilian","year":"2005","journal-title":"Iran J Nucl Med"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib150","first-page":"143","article-title":"Development of [62Zn]bleomycin as a possible PET tracer","volume":"50","author":"Jalilian","year":"2005","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib151","first-page":"108","article-title":"Production and biological evaluation of [18f]-6-thia-14-fluoro-heptadecanoic acid","volume":"9","author":"Jalilian","year":"2006","journal-title":"Nucl Med Rev"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib152","first-page":"163","article-title":"Radiosynthesis and biological evaluation of [18F]-tetracosactide using a semi-automated 18F-SFB production module","volume":"20","author":"Akhlaghi","year":"2009","journal-title":"J Nucl Sci Tech"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib153","first-page":"151","article-title":"Biological Evaluation of [18F]-nifedipine as a novel PET tracer for L-type calcium channel imaging","volume":"53","author":"Sadeghpour","year":"2008","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib154","first-page":"849","article-title":"Radiosynthesis of [18F]-dimethyl 2-(fluoromethyl)-6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate a for L-type calcium channel imaging","volume":"96","author":"Sadeghpour","year":"2008","journal-title":"Radiochimica Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib155","first-page":"373","article-title":"Radiosynthesis of [18F]-5-[2-(2-chlorophenoxy)phenyl]-1,3,4-oxadiazole-2-yl-4-fluorobenzoate a labeled ligand for benzodiazepine receptors","volume":"260","author":"Jalilian","year":"2004","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib156","first-page":"545","article-title":"One-step, no-carrier-added synthesis of a [18F]-Labelled benzodiazepine receptor ligand","volume":"43","author":"Jalilian","year":"2000","journal-title":"J Label Compd Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib157","first-page":"747","article-title":"No-carrier-added 18F-labeling of a cholesteryl derivative, used in detection of adrenal malignancies","volume":"44","author":"Jalilian","year":"2001","journal-title":"J Label Compd Radiopharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib158","first-page":"118","article-title":"A new method for one-step, no-carrier-added synthesis of cholesteryl 4-[18F]-fluorobenzoate ([18F]-CFB), a radiotracer used in detection of adrenal malignancies","volume":"3","author":"Jalilian","year":"2000","journal-title":"J Pharm Pharm Sci"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib159","first-page":"407","article-title":"Synthesis of a [18F] labeled chelidonine derivative as a possible antitumor agent","volume":"54","author":"Jalilian","year":"2001","journal-title":"Appl Radiat Isotopes"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib160","first-page":"45","article-title":"Preclinical studies of [61Cu]ATSM as a PET radiopharmaceutical for fibrosarcoma imaging","volume":"59","author":"Jalilian","year":"2009","journal-title":"Acta Pharm"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib161","first-page":"147","article-title":"Optimization of the production of [61Cu]diacetyl-bis(N4-methylthiosemicarbazone) for PET studies","volume":"269","author":"Jalilian","year":"2006","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib162","first-page":"159","article-title":"61Cu-PTSM in normal rats","volume":"19","author":"Jalilian","year":"2008","journal-title":"J Nucl Sci Technol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib163","first-page":"113","article-title":"Preparation of [61Cu]pyruvaldehyde-bis (N4-methylthiosemicarbazone) complex as a possible PET radiopharmaceutical","volume":"94","author":"Jalilian","year":"2006","journal-title":"Radiochim Acta"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib164","first-page":"175","article-title":"Preparation, quality control and biodistribution studies of [61Cu]-oxinate for PET tumor imaging","volume":"54","author":"Jalilian","year":"2009","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib165","first-page":"157","article-title":"Preparation, quality control and biodistribution studies of [61Cu]-doxorubicin for PET tumor imaging","volume":"20","author":"Jalilian","year":"2009","journal-title":"J Nucl Sci Tech"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib166","first-page":"41","article-title":"Preparation and preclinical evaluation of [61Cu]-thiophene-2-aldehyde thiosemicarbazone for PET studies","volume":"11","author":"Jalilian","year":"2008","journal-title":"Nucl Med Rev"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib167","first-page":"337","article-title":"Preparation of [61Cu]-2-acetylpyridine thiosemicarbazone complex as a possible PET tracer for malignancies","volume":"64","author":"Jalilian","year":"2006","journal-title":"Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib168","first-page":"637","article-title":"Synthesis and preclinical studies of [61Cu]-N-(2-hydroxy acetophenone) glycinate as a possible PET radiopharmaceutical","volume":"276","author":"Jalilian","year":"2008","journal-title":"Sci Pharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib169","first-page":"175","article-title":"Radiosynthesis and preclinical evaluation of [61Cu]-9,10-phenanthrenequinone thiosemicarbazone in fibrosarcoma-bearing animals for PET imaging","volume":"98","author":"Jalilian","year":"2010","journal-title":"Radiochimica Acta"},{"issue":"11","key":"10.1053\/j.semnuclmed.2016.01.006_bib170","first-page":"1035","article-title":"Development of [62Zn\/62Cu]-DOTA-rituximab as a possible novel in vivo PET generator for anti-CD20 antigen imaging","volume":"102","author":"Gholipour","year":"2014","journal-title":"Radiochim Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib171","first-page":"135","article-title":"Preparation and biological evaluation of [61Cu]Bleomycin complex as a possible PET radiopharmaceutical","volume":"54","author":"Jalilian","year":"2009","journal-title":"Nukleonika"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib172","first-page":"111","article-title":"Preparation of [61Cu]DTPA complex as a possible PET tracer","volume":"51","author":"Jalilian","year":"2006","journal-title":"Nukleonika"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.01.006_bib173","first-page":"347","article-title":"Preparation and preliminary evaluation of [55Co](II)vancomycin","volume":"19","author":"Jalilian","year":"2008","journal-title":"J Nucl Sci Technique"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib174","first-page":"567","article-title":"Preparation and biological evaluation of a [55Co]-2-acetylpyridine thiosemicarbazone","volume":"77","author":"Jalilian","year":"2009","journal-title":"Sci Pharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib175","first-page":"21","article-title":"Preparation and evaluation of [55Co](II)DTPA for blood cell labeling","volume":"3","author":"Jalilian","year":"2009","journal-title":"Open Inorg Chem J"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib176","first-page":"155","article-title":"Development of [66Ga]oxine complex: A possible PET tracer","volume":"51","author":"Jalilian","year":"2006","journal-title":"Nukleonika"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib177","first-page":"617","article-title":"Preparation of [66Ga]Bleomycin complex as a possible PET radiopharmaceutical","volume":"264","author":"Jalilian","year":"2005","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib178","first-page":"35","article-title":"Preparation and evaluation of a [66Ga]gallium chitosan complex in fibrosarcoma bearing animal models","volume":"56","author":"Pourjavadi","year":"2011","journal-title":"Nukleonika"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib180","first-page":"209","article-title":"Production, quality control and initial imaging studies of [82mRb]RbCl for PET studies","volume":"51","author":"Rowshanfarzad","year":"2006","journal-title":"Nukleonika"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib181","first-page":"45","article-title":"Simultaneus production and quality control of 73Se and 75Se radioisotopes in a 30MeV cyclotron","volume":"2","author":"Rowshanfarzad","year":"2004","journal-title":"Iran J Radiat Res"},{"issue":"7-8","key":"10.1053\/j.semnuclmed.2016.01.006_bib182","first-page":"1392","article-title":"86Y production via 86Sr(p, n) for PET imaging at a cyclotron","volume":"67","author":"Sadeghi","year":"2009","journal-title":"Appl Radiat Isotopes"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib183","first-page":"97","article-title":"Accelerator production of the positron emitter zirconium-89","volume":"41","author":"Sadeghi","year":"2012","journal-title":"Ann Nucl Energy"},{"issue":"10","key":"10.1053\/j.semnuclmed.2016.01.006_bib184","first-page":"1281","article-title":"Thick tellurium electrodeposition on nickel-coated copper substrate for 124I production","volume":"66","author":"Sadeghi","year":"2008","journal-title":"Appl Radiat Isotopes"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib185","first-page":"94","article-title":"Measurement of thermal neutron capture cross-section and resonance integral for 165Ho(n,\u03b3)166gHo reaction by activation method","volume":"295","author":"Zolghadri","year":"2013","journal-title":"Nucl Instrum Methods Phys Res B"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib186","first-page":"40","article-title":"Production, quality control and biological evaluation of 90Y-EDTMP in rats","volume":"52","author":"Adeli","year":"2010","journal-title":"J Nucl Sci Technol"},{"issue":"10","key":"10.1053\/j.semnuclmed.2016.01.006_bib187","first-page":"1407","article-title":"Production of glass microspheres comprising 90Y and (177)Lu for treating of hepatic tumors with SPECT imaging capabilities","volume":"69","author":"Poorbaygi","year":"2011","journal-title":"Appl Radiat Isotopes"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib188","unstructured":"http:\/\/www.iaea.org\/inis\/collection\/NCLCollectionStore\/_Public\/32\/028\/32028763.pdf"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib189","first-page":"15","article-title":"Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: Comparison of direct and indirect radioiodination methods","volume":"19","author":"Mohammadnejad","year":"2010","journal-title":"Hum Antibodies"},{"issue":"6","key":"10.1053\/j.semnuclmed.2016.01.006_bib190","first-page":"849","article-title":"Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer","volume":"38","author":"Salouti","year":"2011","journal-title":"Nucl Med Biol"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.01.006_bib191","first-page":"949","article-title":"177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer","volume":"37","author":"Rasaneh","year":"2010","journal-title":"Nucl Med Biol"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib192","first-page":"1559","article-title":"Biodistribution evaluation of 166Ho-DTPA-SPION in normal rats","volume":"307","author":"Nosrati","year":"2016","journal-title":"J Radioanal Nucl Chem"},{"issue":"10","key":"10.1053\/j.semnuclmed.2016.01.006_bib193","first-page":"870","article-title":"Preparation, quality control and biodistribution assessment of 153 Sm-BPAMD as a novel agent for bone pain palliation therapy","volume":"29","author":"Rabie","year":"2015","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib194","first-page":"1243","article-title":"Preparation and biological assessment of 177Lu-BPAMD as a high potential agent for bone pain palliation therapy: Comparison with 177Lu-EDTMP","volume":"307","author":"Yousefnia","year":"2016","journal-title":"J Radioanal Nucl Chem"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib195","first-page":"339","article-title":"Production, quality control, biodistribution assessment and preliminary dose evaluation of [177Lu]-tetra phenyl porphyrin complex as a possible therapeutic agent","volume":"51","author":"Zolghadri","year":"2015","journal-title":"Braz J Pharmaceut Sci"},{"issue":"7","key":"10.1053\/j.semnuclmed.2016.01.006_bib196","first-page":"659","article-title":"Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts","volume":"102","author":"Vahidfar","year":"2014","journal-title":"Radiochimica Acta"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib197","first-page":"269","article-title":"Radiosynthesis and biological evaluation of holmium-166 labeled methoxylatedporphyrins as possible therapeutic agents","volume":"301","author":"Vahidfar","year":"2014","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib198","first-page":"269","article-title":"Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent","volume":"301","author":"Vahidfar","year":"2014","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib199","first-page":"35","article-title":"Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as an agent for bone pain palliation","volume":"3","author":"Zolghadri","year":"2015","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib200","first-page":"260","article-title":"Preliminary dosimetric evaluation of\u00a0166Ho-TTHMP for human based on biodistribution data in rats","volume":"94","author":"Yousefnia","year":"2014","journal-title":"Appl Radiat Isot"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib201","first-page":"445","article-title":"The synthesis, radiolabeling and first biological evaluation of a new 166Ho-complex for radiotherapy of bone metastases","volume":"101","author":"Zolghadri","year":"2013","journal-title":"Radiochimica Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib202","first-page":"110","article-title":"Preparation, biological evaluation and dosimetry studies of 175Yb-bis-phosphonates for bone pain palliation therapy","volume":"24","author":"Fakhari","year":"2015","journal-title":"Mol Imaging Radionucl Ther"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib203","first-page":"327","article-title":"Development of 153Sm-folate-PEI conjugated chitosan nanoparticles for targeted therapy purposes","volume":"58","author":"Mollarazi","year":"2015","journal-title":"J Label Compd Radiopharm"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib204","first-page":"105","article-title":"Effects of different carriers for adsorption of 125I on brachytherapy sources","volume":"10","author":"Ghahramani","year":"2012","journal-title":"Iran J Radiat Res"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib205","first-page":"49","article-title":"Results of stereotactic brachytherapy (temporary 125 iodine seeds) for the treatment of low-grade astrocytoma (grade II)","volume":"15","author":"Shahzadi","year":"2013","journal-title":"Iran Red Crescent Med J"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib206","first-page":"1","article-title":"Production, quality control, biological evaluation and biodistribution modeling of Lutetium-177 maltolate as a viable bone pain palliative in skeletal metastasis","volume":"303","author":"Hakimi","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib207","first-page":"265","article-title":"Preparation and Bio-kinetics of samarium-153 maltolate complex as a lanthanide mobilization product in rats","volume":"79","author":"Naseri","year":"2011","journal-title":"Sci Pharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib208","first-page":"743","article-title":"Development of 166Ho-pamidronate for bone pain palliation therapy","volume":"303","author":"Fakhari","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib209","first-page":"87","article-title":"Development of 166Ho-phytate complex for radiosynovectomy","volume":"45","author":"Jalilian","year":"2011","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib210","first-page":"22","article-title":"Development of 177Lu-phytate complex for radiosynovectomy","volume":"3","author":"Yousefnia","year":"2014","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib211","first-page":"28","article-title":"Development of 166Ho-PDTMP as a possible bone palliation agent","volume":"13","author":"Zolghadri","year":"2014","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib212","first-page":"99","article-title":"Production, quality control, biodistribution assessment and preliminary dose evaluation of 177Lu-PDTMP as a possible bone palliative agent","volume":"35","author":"Yousefnia","year":"2013","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib213","first-page":"1273","article-title":"Production, quality control and pharmacokinetic studies of 177Lu-zoledronate for bone pain palliation therapy","volume":"298","author":"Nikzad","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib214","first-page":"1065","article-title":"Production and quality control of [166Ho]-DOTA-bevacizumab for therapeutic applications","volume":"292","author":"Khorami-Moghadam","year":"2012","journal-title":"J Radioanal Nucl Chem"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.01.006_bib215","first-page":"365","article-title":"Preclinical evaluation of holmium-166 labeled anti-VEGF-A(bevacizumab)","volume":"56","author":"Khorami-Moghadam","year":"2013","journal-title":"J Label Compd Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib216","first-page":"37","article-title":"Production, quality control and biodistribution studies of thulium-170-labeled ethylenediamine (tetramethylenephosphonic acid)","volume":"101","author":"Shirvani-Arani","year":"2013","journal-title":"Radiochimica Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib217","first-page":"215","article-title":"Development of a radioscandium immunoconjugate for radioimmunotherapy","volume":"100","author":"Moghaddam-Banaem","year":"2012","journal-title":"Radiochimica Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib218","first-page":"1287","article-title":"Preparation and quality control and biodistribution studies of [90Y]-DOTA-cetuximab for radioimmunotherapy","volume":"296","author":"Vakili","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib219","first-page":"226","article-title":"Evaluation and comparison of human absorbed dose of 90Y-DOTA-cetuximab in various age groups based on distribution data in rats","volume":"37","author":"Vakili","year":"2012","journal-title":"J Med Physics"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib220","first-page":"199","article-title":"Optimization of 90Y-antiCD20 preparation for radioimmunotherapy","volume":"9","author":"Gholipour","year":"2013","journal-title":"J Cancer Res Therapeut"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib221","first-page":"103","article-title":"Development of 170Tm-DOTA-cetuximab for radioimmunotherapy","volume":"55","author":"Shirvani-Arani","year":"2012","journal-title":"J Label Compd Radiopharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib222","first-page":"267","article-title":"Synthesis, quality control and biological evaluation of tris [(1,10-phenanthroline) [153Sm] samarium (III)]trithiocyanate complex as a therapeutic agent","volume":"100","author":"Naseri","year":"2012","journal-title":"RadiochimicaActa"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib223","first-page":"49","article-title":"Preparation and quality control of 177Lu-[tris(1,10-phenanthroline) lutetium(III)] complex for therapy","volume":"13","author":"Yousefnia","year":"2010","journal-title":"Nucl Med Rev"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib224","first-page":"277","article-title":"Preparation, quality control and biodistribution studies of 165Dy-chitosan for radiosynovectomy","volume":"56","author":"Shirvani-Arani","year":"2011","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib225","first-page":"423","article-title":"Production, quality control and pharmacokinetic studies of 166Ho-EDTMP for bone pain palliation therapy","volume":"78","author":"Bahrami-Samani","year":"2010","journal-title":"Sci Pharm"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib226","first-page":"461","article-title":"Development of holmium-166 bleomycin as a possible therapeutic complex","volume":"285","author":"Zolghadri","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib227","first-page":"237","article-title":"Biological studies of samarium-153 bleomycin complex in human breast cancer murine xenografts for therapeutic applications","volume":"98","author":"Bahrami-Samani","year":"2010","journal-title":"Radiochimica Acta"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib228","first-page":"237","article-title":"Preparation and quality control of 166Ho-DTPA-antiCD20 for radioimmunotherapy","volume":"99","author":"Zolghadri","year":"2011","journal-title":"Radiochimica Acta"},{"issue":"4","key":"10.1053\/j.semnuclmed.2016.01.006_bib229","first-page":"271","article-title":"Development of 153Sm-DTPA-Rituximab for radioimmunotherapy","volume":"54","author":"Bahrami-Samani","year":"2009","journal-title":"Nukleonika"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib230","first-page":"199","article-title":"Development of 177Lu-DOTA-anti-CD20 for radioimmunotherapy","volume":"287","author":"Yousefnia","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib231","first-page":"865","article-title":"Development of [103Pd]-labeled-bis(N4-methylthiosemicarbazone) complexes as possible therapeutic agents","volume":"94","author":"Jalilian","year":"2006","journal-title":"Radiochimica Acta"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib232","first-page":"605","article-title":"Development of [103Pd]-2-Acetylpyridine 4N-methyl thiosemicarbazone complex for targetedtherapy","volume":"268","author":"Jalilian","year":"2006","journal-title":"J Radioanal Nucl Chem"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.01.006_bib233","first-page":"519","article-title":"Dosimetry of (32)Pradiocolloid for treatment of cystic craniopharyngioma","volume":"65","author":"Sadeghi","year":"2007","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib234","first-page":"113","article-title":"Targetry and radiochemistry for no-carrier-added production of 109 Cd","volume":"97","author":"Sadeghi","year":"2009","journal-title":"Radiochimica Acta"},{"issue":"2","key":"10.1053\/j.semnuclmed.2016.01.006_bib235","first-page":"585","article-title":"Production of 122 Sb for the study of environmental pollution","volume":"287","author":"Sadeghi","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"issue":"8","key":"10.1053\/j.semnuclmed.2016.01.006_bib236","first-page":"529","article-title":"Internal radiotherapy techniques using radiolanthanide praseodymium-142: A review of production routes, brachytherapy, unsealed source therapy","volume":"25","author":"Bakht","year":"2011","journal-title":"Ann Nucl Med."},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib237","first-page":"53","article-title":"A novel technique for simultaneous diagnosis and radioprotection by radioactive cerium oxide nanoparticles: Study of cyclotron production of 137m Ce","volume":"292","author":"Bakht","year":"2013","journal-title":"J Nucl Chem"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib238","first-page":"259","article-title":"Study of the cyclotron production of 172 Lu: An excellent radiotracer","volume":"286","author":"Sadeghi","year":"2010","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1053\/j.semnuclmed.2016.01.006_bib239","first-page":"361","article-title":"Cyclotron production of 169 Yb: A potential radiolanthanide for brachytherapy","volume":"289","author":"Nadi","year":"2011","journal-title":"J Radioanal Nucl Chem"},{"issue":"5","key":"10.1053\/j.semnuclmed.2016.01.006_bib240","first-page":"539","article-title":"Production and radiochemical separation of no-carrier-added 88 Y by liquid-liquid extraction","volume":"53","author":"Sadeghi","year":"2011","journal-title":"Radiochemistry"},{"issue":"1","key":"10.1053\/j.semnuclmed.2016.01.006_bib241","first-page":"167","article-title":"Targetry for 48V production and the nuclear model calculation on the charge particle induced reaction on Ti target","volume":"293","author":"Sadeghi","year":"2012","journal-title":"J Radioanal Nucl Chem"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib242","first-page":"115","article-title":"Preparation, biodistribution and stability of [65Zn]bleomycin complex","volume":"12","author":"Jalilian","year":"2004","journal-title":"Daru"},{"issue":"3","key":"10.1053\/j.semnuclmed.2016.01.006_bib243","first-page":"97","article-title":"Production and quality control of 65Zn radioisotope","volume":"50","author":"Rowshanfarzad","year":"2005","journal-title":"Nukleonika"}],"updated-by":[{"DOI":"10.1053\/j.semnuclmed.2016.07.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000}}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299816000076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299816000076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:33:36Z","timestamp":1757543616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299816000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":241,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0001299816000076"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2016.01.006","relation":{"erratum":[{"id-type":"doi","id":"10.1053\/j.semnuclmed.2016.07.008","asserted-by":"object"}]},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2016.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}